*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Emmeline Blanchard
BME Ph.D. Defense Presentation
Date: October 11, 2019
Time: 9 AM EST
Location: IBB Suddath Seminar Room 1128
Advisor: Dr. Philip Santangelo
Committee Members: Dr. Krishnendu Roy, Dr. M.G. Finn, Dr. Gary Bassell, Dr. Erik Dreaden
Title: Characterizing protein-protein and RNA-protein interactions in fixed cells and tissue
Abstract:
The molecular machinery of the cell is governed by interactions between proteins, DNA, and RNA. For example, innate immune system activation is characterized by the formation and disassociation of protein complexes in a signaling cascade. Alternatively, protein interactions with mRNA control the transcription, transport, and stability of mRNA. Resultingly, abnormal interactions disrupt function, contributing to tumorigenesis. Similarly, protein-protein and protein-RNA interactions in the ribonucleocapsid complex of respiratory syncytial virus govern transcription and replication of the virus.
To gain a better understanding of these interactions, a thorough investigation is required in cells and tissue samples. Conventionally used tools to study interactions are often limited in their specificity and sensitivity. The overall goal of the work presented here was to demonstrate and develop a toolbox to quantify and localize protein-protein and RNA-protein interactions in fixed cells and tissues, and to use these tools to gain insight into the role of molecular interactions in several applications. First, we demonstrated the utility of proximity ligation assays to measure innate immune system activation in both cells and tissue. Next, we developed a methodology of measuring mRNA-protein interactions in archival, patient-derived tissue, specifically examining abnormal mRNA-protein interactions in cancer. Finally, we used proximity ligation assays and our developed methodology to investigate the role of the respiratory syncytial virus ribonucleocapsid complex in the transcription/replication switch in infection. We believe these methods are easy to use and highly translatable to new applications, and therefore of great interest to research where molecular interactions are of importance.
